Clinical Trial Update: Single Dose Study of the Fluticasone/Salmeterol (500/50 μg) Administered With Elpenhaler® Versus Diskus® [Phase 3]

View source ↗

Summary

Phase 3 trial comparing single-dose Fluticasone/Salmeterol 500/50 μg delivered by Elpenhaler vs Diskus in asthma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone/Salmeterol (fluticasone/salmeterol)

Snippet

Sponsor: Elpen Pharmaceutical Co. Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED